Oxford Instruments PLC

Oxford Instruments PLC (LSE: OXIG), a constituent of the FTSE 250 Index, is a global provider of high-technology solutions for industrial and scientific applications. The company specializes in advanced instrumentation and analytical systems across three key market segments: materials analysis, semiconductors, and healthcare & life sciences. Its operations are divided into two core business segments: Imaging & Analysis, which focuses on microscopy, scientific cameras, and analytical instrumentation; and Advanced Technologies, which develops innovative systems for industrial and research applications.

Key Recommendation Rationale – Sell at GBX 1,916.32

• Deterioration in Statutory Profitability: The statutory operating profit and profit before tax have experienced a substantial decline year-over-year. Operating profit fell by 42.6%, and profit before tax decreased by 44.2%. This indicates that, on the reported statutory basis, which includes all adjusting items, the company's core profitability was significantly lower than in the prior year, raising concerns about its underlying cost structure or one-off negative impacts.

• Sharp Contraction in Statutory Operating Margin: The statutory operating margin contracted by 670 basis points, dropping from 14.5% to 7.8%. This is a material decline that suggests either rising costs are outpacing revenue growth, or the revenue being generated is of a lower-margin nature. This level of margin compression can affect the company's ability to fund future investments from operational earnings.

• Decline in Return on Capital Employed: The Return on Capital Employed (ROCE) decreased from 29.1% to 27.1%. This indicates that the company is generating less profit from each unit of capital invested in the business. A declining ROCE can signal reducing efficiency in the use of capital, potentially pointing to investments that have not yet yielded adequate returns or a deterioration in the profitability of existing assets. 

Valuation Methodology: Price/ Earnings Approach

Share Price Chart  

One-Year Technical Price Chart (as of September 09, 2025). Source: TradingView, Analysis: Kalkine Group

Conclusion

The presented financial data indicates a period where the company's statutory profitability and capital efficiency have faced pressure. The material declines in both absolute profit figures and operating margin point to challenges in maintaining previous earnings levels, potentially due to cost inflation or a shift in revenue mix. Concurrently, the reduction in return on capital employed suggests a decrease in the efficiency with which the company's capital base is generating profits. Together, these trends reflect a period of compression in core financial performance and raise questions regarding the near-term outlook for earnings power and investment returns.

OXIG appears overvalued. For conducting the valuation, the following peers have been considered: IMI PLC (LSE: IMI), Discoverie Group PLC (LSE: DSCV), etc

Given its current trading levels, the recent strategic investments and partnerships, relative valuation, and associated risks, it is prudent to exit the stock at the current levels. Hence, a ‘Sell’ recommendation is given on the stock at the Current Market Price of GBX 1,916.32 as of 09 September 2025, 08:00 AM, GMT+1. 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 09 September 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’